MetaCap

agilon health inc. (AGL)

NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD

90.24+0.74 (+0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AGL stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$6.69
52-week range
7.48 – 133.04
Day range
85.77 – 90.27
Volume / Avg
266.32K / 226.26K
Beta
—

52-week range

$7.48$133.04

AGL stock today

On Nov 20, AGL ended the session at $90.24, adding $0.74 (0.83%), versus the S&P 500's 3.70% decline. At this level, AGL sits in the middle of its 52-week range of $7.48 to $133.04: 32.2% below the high, set on Jul 17, 2026 and 1106.4% above the low. AGL is up 423.9% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 481.3%.

agilon health inc. has posted a net loss over the last twelve months (EPS of -$6.69), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About agilon health inc.

Company profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.

Industry
Misc Health and Biotechnology Services
CEO
Mr. Timothy Patrick O'Rourke
Headquarters
Westerville, OH
Employees
856
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, agilon health inc. generated $5.93 billion in revenue, down 2.1% from fiscal 2024, the first decline in the 7 years shown. agilon health inc. reported a net loss of $391.3 million, compared with a loss of $260.2 million a year earlier. Operating margin was -7.8%.

agilon health inc. annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$5.93B$6.06B$4.32B$2.39B$1.52B
Growth-2.11%+40.41%+80.74%+56.97%+24.88%
Net income$-391.35M$-260.15M$-262.60M$-106.55M$-406.49M
EPS (diluted)$-0.98$-0.61$-0.48$-0.22$-1.03

Analyst forecast

Forecast

Consensus (15 analysts)

buy

Avg. price target

$124.83+38.33%

  • Strong buy 0
  • Buy 5
  • Hold 9
  • Sell 0
  • Strong sell 1

Target range

Low $105.00High $170.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$1.97 vs $-2.01
Surprise
+198.01%

AGL news

All AGL news

agilon health inc. peers

Health Care sector
AGL peer companies
CompanyPrice% ChgMarket capCompare
PGNYProgyny Inc.35.71+0.73%$2.63Bvs AGL
VMDViemed Healthcare Inc.8.52-1.05%$322.85Mvs AGL
PARKPark Dental Partners Inc.17.03-6.79%$94.26Mvs AGL
CCELCryo-Cell International Inc.4.150.00%$33.46Mvs AGL
MGRXMangoceuticals Inc.0.1236-7.55%$2.75Mvs AGL
NIVFNewGenIvf Group Limited Class A0.0269-23.14%$80.77Kvs AGL
SHCSotera Health Company15.91-1.85%$4.54Bvs AGL
DVADaVita Inc.161.03+3.00%$10.13Bvs AGL

Indexes, lists and sector

agilon health inc. stock FAQ

What is agilon health inc.'s stock price today?

AGL last traded at $90.24 as of Nov 20, 4:00 PM EST, up 0.83% on the day. Prices are delayed at least 15 minutes.

Does agilon health inc. pay a dividend?

No. agilon health inc. does not currently pay a regular cash dividend.

Who is agilon health inc.'s CEO?

Mr. Timothy Patrick O'Rourke is the chief executive officer of agilon health inc., which has about 856 employees.

Has AGL ever split its stock?

Yes. The most recent AGL stock split was a 1-for-25 split on Mar 31, 2026.

What is the AGL 52-week high?

The 52-week high for AGL is $133.04 and the 52-week low is $7.48. The stock is currently 32.2% below its high.

Compare AGL